Interactions between cyclodextrins and pilocarpine - as an example of a hydrophilic drug

International Journal of Pharmaceutics

Volumn 142, Issue 2, 1996, Pages 153-162

  Keipert, S ^a   Feeder, J ^a   Bohm A ^a   Hanke, B ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Cyclodextrin; In vitro release; Inclusion complex; Miotic bioavailability; Physicochemical properties; Physiological compatibility; Pilocarpine; Solid dispersion

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; ALPHA CYCLODEXTRIN; BETA CYCLODEXTRIN; CYCLODEXTRIN; GAMMA CYCLODEXTRIN; PILOCARPINE;

ANIMAL EXPERIMENT; ARTICLE; BIOAVAILABILITY; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG RELEASE; FOURIER TRANSFORMATION; MIOSIS; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RABBIT; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SCANNING ELECTRON MICROSCOPY; TOPICAL DRUG ADMINISTRATION; X RAY DIFFRACTION;

EID: 0030580131     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5173(96)04660-1     Document Type: Article

References (14)

1. Böhm, A.-K., Untersuchungen zur Einschlußbildung von Cyclodextrinen mit hydrophilen Pharmaka am Beispiel des Pilocarpins. Diploma, Humboldt University, Berlin, 1991.
2. Hanke, B., Untersuchungen zur Einschlußbildung zwischen Pilocarpin und Cyclodextrinen in wässeriger Lösung. Diploma, Humboldt University, Berlin, 1993.
3. Hilton, M.L. and Armstrong, D.W., Contribution of cyclodextrins and derivatives to liquid chromatography. New Trends in Cyclodextrins and Derivatives, Editions de Santé, Paris, 1991, pp. 517-549.
4. Keipert, S., Etablierte und neue Konzepte zur Optimierung von Ophthalmika. Pharm. Ztg., 139 (1994) 567-576.
5. Keipert, S. and Schulz, G., Mikroemulsionen auf Saccharoseesterbasis, Teil 1: In vitro-Charakterisierung. Pharmazie, 49 (1994), 195-197.
6. Keipert, S. and Siebenbrodt, I., Antiglaukomatosahaltige Ophthalmika mit prolongierter Wirkung auf Basis makromolekularer Hilfsstoffe, Teil 3: Optimierte, tropfbare Rezepturen auf Polyacrylatbasis. Pharmazie, 45 (1990) 596-599.
7. Luepke, N.P., Hen's egg chorionallantoic membrane test for irritation potential. Fd. Chem. Toxic., 23 (1985) 135-138.
8. Pergande, G., Keipert, S. and Klatt, A., Antiglaukomatosahaltige Ophthalmika mit prolongierter Wirkung auf Basis makromolekularer Hilfsstoffe, Teil 2: In vivo-Untersuchungen. Pharmazie, 45 (1990) 587-591.
9. Puglisi, G., Santagati, N.A., Pignatello, R., Ventura, C., Bottino, F.A., Mangiafico, S. and Mazzone, G., Inclusion complexation of 4-biphenylacetic acid with β-cyclodextrin. Drug Dev. Ind. Pharm., 16(3) (1990) 395-413.
10. Uekama, K., Arima, H., Irie, T., Matsubara, K. and Kuriki, T., Sustained release of buserelin acetate, a luteinizing hormone-releasing hormone agonist, from an injectable oily preparation utilizing ethylated β-cyclodextrin. J. Pharm. Pharmacol., 41 (1989) 874-876.
11. Uekama, K., Hirayama, F. and Irie, T., The new method for determination of the stability constants of cyclodextrin-prostaglandin inclusion complexes by liquid chromatography. Chem. Lett., (1978) 661-664.
12. Uekama, K., Hirayama, F. and Irie, T., Release control of water-soluble drugs by β-cyclodextrin-derivatives. In Duchêne D., (Ed.), Minutes of the 5th International Symposium on Cyclodextrins, Editions de Santé, Paris 1990, pp. 418-423.
13. Wiesend, B., Die Bestimmung von Pilocarpin und seinen Zersetzungsprodukten mit ewiner neuen HPLC-Methode. Pharm. Ztg. Wiss., 133(1) (1988) 44-47.
14. Yoshida, A., Arima, H., Uekama, K. and Pitha, J., Pharmaceutical evaluation of hydroxyalkyl ethers of β-cyclodextrins. Int. J. Pharm., 46 (1988) 217-222.